Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Two AstraZeneca shots could be 85-90% effective, UK data suggests

Stock Markets May 20, 2021 01:25PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A dose of AstraZeneca vaccine is prepared at COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. REUTERS/Andrew Couldridge/File Photo

By Alistair Smout

LONDON (Reuters) -Two doses of the Oxford/AstraZeneca COVID-19 vaccine may be around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday, while cautioning that it did not yet have enough data to be conclusive.

Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine rollouts, generating a lot of data about the use of the shots in real-world settings.

It was the first country to roll out AstraZeneca (NASDAQ:AZN)'s vaccine, which faced questions over the construction of its clinical trials, the efficacy of the vaccine and the optimal gap between doses of its shot.

PHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but cautioned that it had "low confidence" in the findings, and the results would be inconclusive until more evidence was gathered.

In a weekly surveillance report, Public Health England said the estimated effectiveness of the AstraZeneca vaccine, invented at the University of Oxford, was 89% compared to unvaccinated people.

That compares to 90% estimated effectiveness against symptomatic disease for the Pfizer/BioNTech vaccine.

"This new data highlights the incredible impact that both doses of the vaccine can have, with a second dose of the Oxford/AstraZeneca vaccine providing up to 90% protection," vaccines minister Nadhim Zahawi said.

AstraZeneca welcomed the preliminary findings.

"This latest real-world data from PHE adds to the growing body of evidence that demonstrates the effectiveness of our vaccine against COVID-19," a spokesman said.

"It is reassuring to see the data from both the Pfizer (NYSE:PFE) and Oxford AstraZeneca vaccines. They are essentially comparable in terms of effectiveness against symptomatic disease, which is very high after two doses," said Michael Head, Senior Research Fellow in Global Health at the University of Southampton.

Britain has been rolling out the shots manufactured by Pfizer and AstraZeneca since December and January respectively, and in April also started deploying Moderna (NASDAQ:MRNA)'s vaccine.

PHE said there was a "small reduction in vaccine effectiveness" from 10 weeks after the first dose of the Pfizer shot before the second shot is given.

Britain extended the gap between doses to 12 weeks, though Pfizer warned there was a lack of evidence of its efficacy outside the three-week gap used in trials.

Last week, Britain cut the gap between doses down to 8 weeks for the over 50s, aiming to give maximum protection to more vulnerable people in light of concern about the B.1.617.2 variant first found in India.

Two AstraZeneca shots could be 85-90% effective, UK data suggests
 

Related Articles

GE CEO Culp expands role to head aviation unit
GE CEO Culp expands role to head aviation unit By Reuters - Jun 27, 2022 2

By Rajesh Kumar Singh, Tim Hepher and Abhijith Ganapavaram (Reuters) -General Electric Co said on Monday Chief Executive Larry Culp will also head its aviation unit effective...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (4)
Felipe Daniel
Felipe Daniel May 20, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Does public know the jabs have not approved by FDA only under “emergency” authorization. Yikes!
Dave Wastreet
Dave Wastreet May 20, 2021 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fake news
Felipe Daniel
Felipe Daniel May 20, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The first one gives you blood clots but two is fine...
danny Levine
danny Levine May 20, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol good one
Barou Bayaro
Barou Bayaro May 20, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bonjour xava gievmy 100$
Barou Bayaro
Barou Bayaro May 20, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
merci beaucoup
danny Levine
danny Levine May 20, 2021 10:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol who still trusts all these fake numbers. first it was 50%, then 80%, what's next, 120%?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email